BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28931441)

  • 1. Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.
    Blackmore T; Meftah S; Murray TK; Craig PJ; Blockeel A; Phillips K; Eastwood B; O'Neill MJ; Marston H; Ahmed Z; Gilmour G; Gastambide F
    Alzheimers Res Ther; 2017 Sep; 9(1):77. PubMed ID: 28931441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
    Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
    PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model.
    Jul P; Volbracht C; de Jong IE; Helboe L; Elvang AB; Pedersen JT
    J Alzheimers Dis; 2016; 49(3):783-95. PubMed ID: 26519432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
    Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
    Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model.
    Bailey RM; Howard J; Knight J; Sahara N; Dickson DW; Lewis J
    Mol Neurodegener; 2014 Jan; 9():8. PubMed ID: 24428919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.
    Yue M; Hanna A; Wilson J; Roder H; Janus C
    Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration.
    Holton CM; Hanley N; Shanks E; Oxley P; McCarthy A; Eastwood BJ; Murray TK; Nickerson A; Wafford KA
    Alzheimers Res Ther; 2020 Jul; 12(1):84. PubMed ID: 32669112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510).
    Kim J; Choi IY; Duff KE; Lee P
    Neurochem Res; 2017 Jun; 42(6):1649-1660. PubMed ID: 28523532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy.
    Blair LJ; Frauen HD; Zhang B; Nordhues BA; Bijan S; Lin YC; Zamudio F; Hernandez LD; Sabbagh JJ; Selenica ML; Dickey CA
    Acta Neuropathol Commun; 2015 Jan; 3():8. PubMed ID: 25775028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.
    Song L; Lu SX; Ouyang X; Melchor J; Lee J; Terracina G; Wang X; Hyde L; Hess JF; Parker EM; Zhang L
    Mol Neurodegener; 2015 Mar; 10():14. PubMed ID: 25881209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.
    Barten DM; Fanara P; Andorfer C; Hoque N; Wong PY; Husted KH; Cadelina GW; Decarr LB; Yang L; Liu V; Fessler C; Protassio J; Riff T; Turner H; Janus CG; Sankaranarayanan S; Polson C; Meredith JE; Gray G; Hanna A; Olson RE; Kim SH; Vite GD; Lee FY; Albright CF
    J Neurosci; 2012 May; 32(21):7137-45. PubMed ID: 22623658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent impairment of memory and neurofibrillary tangle formation and clearance in a mouse model of tauopathy.
    Kubota T; Kirino Y
    Brain Res; 2021 Aug; 1765():147496. PubMed ID: 33894222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice.
    Keenan RJ; Daykin H; Metha J; Cornthwaite-Duncan L; Wright DK; Clarke K; Oberrauch S; Brian M; Stephenson S; Nowell CJ; Allocca G; Barnham KJ; Hoyer D; Jacobson LH
    Br J Pharmacol; 2024 Jan; 181(1):87-106. PubMed ID: 37553894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive functional impairments of hippocampal neurons in a tauopathy mouse model.
    Ciupek SM; Cheng J; Ali YO; Lu HC; Ji D
    J Neurosci; 2015 May; 35(21):8118-31. PubMed ID: 26019329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cornel Iridoid Glycoside Suppresses Hyperactivity Phenotype in rTg4510 Mice through Reducing Tau Pathology and Improving Synaptic Dysfunction.
    Ma DL; Luo Y; Huang R; Zhao ZR; Zhang L; Li YL; Wang Q; Li L; Zhang L
    Curr Med Sci; 2020 Dec; 40(6):1031-1039. PubMed ID: 33428130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of tau pathology in male rTg4510 mice fed with a curcumin derivative Shiga-Y5.
    Yanagisawa D; Hamezah HS; Durani LW; Taguchi H; Tooyama I
    PLoS One; 2018; 13(12):e0208440. PubMed ID: 30521594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy.
    Dalby NO; Volbracht C; Helboe L; Larsen PH; Jensen HS; Egebjerg J; Elvang AB
    J Alzheimers Dis; 2014; 40(2):429-42. PubMed ID: 24448785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.